Treatment strategies designed to minimize medical complications of allergic rhinitis

American Journal of Rhinology

Volumn 11, Issue 2, 1997, Pages 95-102

  Fireman, Philip ^a,b  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; ASTEMIZOLE; BECLOMETASONE; BUDESONIDE; CETIRIZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DECONGESTIVE AGENT; FEXOFENADINE; FLUNISOLIDE; FLUTICASONE; IPRATROPIUM BROMIDE; LORATADINE; PSEUDOEPHEDRINE; TERFENADINE; TRIAMCINOLONE;

ALLERGIC RHINITIS; COMPLICATION; DESENSITIZATION; DRUG CHOICE; HUMAN; INTRANASAL DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; REVIEW; SYMPTOM; TOPICAL DRUG ADMINISTRATION;

EID: 0030975163     PISSN: 10506586     EISSN: None     Source Type: Journal    
DOI: 10.2500/105065897782537142     Document Type: Review

References (42)

1. White MV, Kaliner MA. Mediators of allergic rhinitis. J Allergy Clin Immunol 90:699-704, 1992.
2. McMenamin P. Costs of hay fever in the United States in 1990. Ann Allergy 73:35-39, 1994.
3. Bousquet J, Bullinger M, Fayol C, et al. Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire. J Allergy Clin Immunol 94:182-188, 1994.
4. Marshall PS, Colon EA. Effects of allergy season on mood and cognitive function. Ann Allergy 71:251-258, 1993.
5. Vuurman EF, van Veggel LM, Uiterwijk MM, et al. Seasonal allergic rhinitis and antihistamine effects on children's learning. Ann Allergy 71:121-126, 1993.
6. Naclerio RM, Meier HL, Kagey-Sobotka A, et al. Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis 128:597-602, 1983.
7. Naclerio RM. The pathophysiology of allergic rhinitis: Impact of therapeutic intervention. J Allergy Clin Immunol 82:927-934, 1988.
8. Slavin RG. Sinusitis in adults and its relation to allergic rhinitis, asthma, and nasal polyps. J Allergy Clin Immunol 82:950-956, 1988.
9. Hinriksdottis I, Melen I. Allergic rhinitis and upper respiratory tract infections. Acta Otolaryngol Suppl 515:30-32, 1994.
10. Stanley PJ, Wilson R, Greenstone MA, et al. Abnormal nasal mucociliary clearance in patients with rhinitis and its relationship to concomitant chest disease. Br J Dis Chest 79:77-82, 1985.
11. De PR. Secretory otitis media and allergic rhinitis. J Laryngol Otol 94:185-189, 1980.
12. Friedman R, Doyle JW, Casselbrant ML, Bluestone CD, Fireman P. Immunologic mediated eustachian tube obstruction: A double-blind cross-over study. J Allergy Clin Immunol 71:442-447, 1983.
13. Skoner DP, Doyle WJ, Chamovitz AF, Fireman P. Eustachian tube obstruction after intranasal challenge with house dust mite. Arch Otolaryngol Head Neck Surg 112:840-842, 1986.
14. Crifo S, Cittadini S, DeSeta E, Andriani G. Eustachian tube permeability during the nasal provocation test. Rhinology 15:81-85, 1977.
15. Shapiro GG. The role of nasal airway obstruction in sinus disease and facial development. J Allergy Clin Immunol 82:935-940, 1988.
16. Hannuksela A, Vaananen A. Predisposing factors for malocclusion in 7-year-old children with special reference to atopic diseases. Am J Ortho Dentofacial Orthop 92:299-303, 1987.
17. Murray AB, Anderson DO. The association of incisor protrusion with digit sucking and allergic nasal itching. J Allergy 44:239-247, 1969.
18. Settipane GA, Chaffee FH. Nasal polyps and rhinitis: a review of 6037 patients. J Allergy Clin Immunol 59:17-21, 1977.
19. Marsden D. Nasal polyposis in children. South Med J 71:911-913, 1978.
20. McNicholas WT, Tarlo S, Cole P, et al. Obstructive apneas during sleep in patients with seasonal allergic rhinitis. Am Rev Respir Dis 126:625-628, 1982.
21. Cowart BJ, Flynn-Rodden K, McGeady SJ, Lowery LD. Hyposmia in allergic rhinitis. J Allergy Clin Immunol 91:747-751, 1993.
22. Ninan TK, Russell G. Respiratory symptoms and atopy in Aberdeen schoolchildren: evidence from two surveys 25 years apart. Br Med J 304:873-875, 1992.
23. Pedersen PA, Weeke ER. Asthma and allergic rhinitis in the same patients. Allergy 38:25-29, 1983.
24. Kaplan B A, Mascie-Taylor CG. Predicting the duration of childhood asthma. J Asthma 29:39-48, 1992.
25. Luoma R, Koivikko A, Viander M. Development of asthma, allergic rhinitis, and atopic dermatitis by the age of five years. A prospective study of 543 newborns. Allergy 38:339-346, 1983.
26. Platts-Mills TA, Thomas WR, Aalberse RC, et al. Dust mite allergens and asthma: Report of a second international workshop. J Allergy Clin Immunol 89:1046-1060, 1992.
27. 1-receptor antagonists: clinical pharmacology and therapeutics. J Allergy Clin Immunol 84:845-861, 1989.
28. 1 antihistamines. Ann Allergy 67:625-633, 1991.
29. 1 antihistamines. In: New Perspectives in Histamine Research. Basel: Birkhäuser Verlag, 181-196, 1991.
30. Neves-Pinto RM, Moreira Lima G, da Mota Teixeira R. A double-blind study of the effects of loratadine versus placebo on the performance of pilots. Am J Rhinol 6:23-27, 1992.
31. Adelsberg BR, D'Amico-Beadon. The effects of loratadine, diphenhydramine and placebo on worker productivity: Results of a double-blind trial. J Allergy Clin Immunol 85:296. 1990, Abstract.
32. Falliers CJ, Brandon ML, Buchman E, et al. Double-blind comparison of cetirizine and placebo in the treatment of seasonal rhinitis. Ann Allergy 66:257-262, 1991.
33. Pfizer's Reactive (cetirizine) is effective for allergic rhinitis. Health News Daily, F-D-C Reports, Inc; 4, 1993.
34. Bruttmann G, Charpin D, Germouty J, et al. Evaluation of the efficacy and safety of loratadine in perennial allergic rhinitis. J Allergy Clin Immunol 83:411-416, 1989.
35. Gutkowski A, Bedard P, Del Carpio J, et al. Comparison of the efficacy and safety of loratadine, terfenadine, and placebo in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 81:902-907, 1988.
36. Chervinsky P, Georgitis J, Banov C, et al. Once daily loratadine versus astemizole once daily. Ann Allergy 73:109-113, 1994.
37. Paris DG, Parente TF, Bruschetta HR, et al. Torsades de pointes induced by erythrpmycin and terfenadine. Am J Emerg Med 12:636-638, 1994.
38. Physicians' Desk Reference. 48th ed. Montvale NJ: Medical Economics Data, 1994.
39. Kobayashi RH, Kiechel F, Kobayashi AL, Mellion MB. Topical nasal sprays: Treatment of allergic rhinitis. Am Fam Physician 50:151-157, 1994.
40. Hébert J, Bédard P-M, DelCario, et al. Loratadine and pseudoephedrine sulfate: A double-blind, placebo-controlled comparison of a combination tablet (SCH434) and its individual components in seasonal allergic rhinitis. Am J Rhinol 2:71-75, 1988.
41. Mygind N, Clark TJH. Safety and topical side-effects. In: Mygind N, Clark TJH, eds. Topical Steroid Treatment for Asthma and Rhinitis. London: Balliere Tindall, 1980.
42. Holopainen E, Malmberg H, Binder E. Long-term follow-up of intranasal beclomethasone treatment. A clinical and histologic study. Acta Otolaryngol 386(suppl):270-273, 1982.